Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
7.29
-0.11 (-1.49%)
Oct 16, 2026, 4:00 PM EDT - Market closed

Oculis Holding AG Revenue

Oculis Holding AG had revenue of 310.00K CHF in the quarter ending June 30, 2026, with 18.77% growth. This brings the company's revenue in the last twelve months to 1.17M, up 53.33% year-over-year. In the year 2025, Oculis Holding AG had annual revenue of 1.20M with 74.78% growth. That makes Oculis Holding AG the 43,005th largest company in the world by revenue and 5,935th in the United States.

Revenue (ttm)
1.17M CHF
Revenue Growth
+53.33%
P/S Ratio
309.99
Revenue / Employee
19,550 CHF
Employees
60
Market Cap
450.03M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.20M513.00K74.78%
Dec 31, 2024686.00K-197.00K-22.31%
Dec 31, 2023883.00K-29.00K-3.18%
Dec 31, 2022912.00K-48.00K-5.00%
Dec 31, 2021960.00K-33.00K-3.32%
Dec 31, 2020993.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Arvinas316.70M
REGENXBIO174.48M
Autolus Therapeutics117.39M
Allogene Therapeutics4.64M
YD Bio1.24M
Neurogene925.00K
Altimmune31.00K
Revenue Rankings